自闭症人群共病精神健康诊断的患病率:系统综述与荟萃分析
该系统综述与荟萃分析检索了1993年至2019年的多个数据库,纳入100项观察性研究(96项进入荟萃分析),评估自闭症人群中共病精神健康诊断的患病率。结果显示注意缺陷多动障碍的合并患病率为28%,焦虑障碍为20%,睡眠-觉醒障碍为13%,抑郁障碍为11%,精神分裂症谱系障碍为4%等,且多数共病患病率高于一般人群。作者建议将心理健康评估整合到自闭症患者的常规临床照护中。
要点
- 自闭症人群中共病精神健康诊断常见,注意缺陷多动障碍合并患病率最高(28%)。
- 焦虑障碍(20%)、睡眠-觉醒障碍(13%)、抑郁障碍(11%)的合并患病率也较高。
- 临床样本研究中的患病率高于人群或登记研究,且多数高于一般人群。
核心结论
- 自闭症人群中精神健康共病患病率高于一般人群,应常规进行心理健康评估并整合到临床实践中。
研究设计与样本
- 系统综述与荟萃分析,检索MEDLINE、Embase、PsycINFO、Scopus、Web of Science及灰色文献中1993年1月1日至2019年2月1日发表的英文或法文观察性原始研究。
- 纳入标准为报告自闭症人群中共病精神健康诊断患病率,且共病诊断与自闭症均基于DSM或ICD标准确认。
- 共纳入100项研究进行定性合成,其中96项进入荟萃分析,采用随机效应模型计算合并患病率。
主要发现
- 注意缺陷多动障碍的合并患病率为28%(95%CI 25-32)。
- 焦虑障碍的合并患病率为20%(95%CI 17-23)。
- 睡眠-觉醒障碍的合并患病率为13%(95%CI 9-17)。
- 破坏性、冲动控制及品行障碍的合并患病率为12%(95%CI 10-15)。
- 抑郁障碍的合并患病率为11%(95%CI 9-13)。
关键数值与推荐
- 强迫症合并患病率为9%(95%CI 7-10)。
- 双相障碍合并患病率为5%(95%CI 3-6)。
- 精神分裂症谱系障碍合并患病率为4%(95%CI 3-5)。
- 年龄、性别、智力功能和研究国家与患病率估计的异质性相关,未解释的异质性仍很大(所有I2 >95%)。
临床怎么用
- 对所有自闭症谱系人群应仔细评估心理健康状况,并将其作为照护的基本组成部分。
- 临床样本中患病率较高,提示临床实践中需警惕共病,尤其是注意缺陷多动障碍和焦虑障碍。
局限性
- 未解释的异质性仍很大(所有I2 >95%)。
- 与一般人群患病率的比较为事后描述性比较。
- 创伤和应激相关障碍、物质相关及成瘾障碍、性别烦躁三类共病仅做描述性合成,未纳入荟萃分析。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Co-occurring mental health or psychiatric conditions are common in autism, impairing quality of life. Reported prevalences of co-occurring mental health or psychiatric conditions in people with autism range widely. Improved prevalence estimates and identification of moderators are needed to enhance recognition and care, and to guide future research. METHODS: In this systematic review and meta-analysis, we searched MEDLINE, Embase, PsycINFO, Scopus, Web of Science, and grey literature for publications between Jan 1, 1993, and Feb 1, 2019, in English or French, that reported original research using an observational design on the prevalence of co-occurring mental health conditions in people with autism and reported confirmed clinical diagnoses of the co-occurring conditions and autism using DSM or ICD criteria. For co-occurring mental health conditions reported with at least 15 datapoints (studies), we assessed risk of bias and we determined pooled estimates of prevalence for different co-occurring conditions in autism using random-effects models, and descriptively compared these with prevalence estimates for the general population from the literature (post hoc). We investigated heterogeneity in prevalence estimates using random-effects meta-regression models. This systematic review is registered with PROSPERO, CRD42018103176. FINDINGS: Of 9746 unique studies identified, 432 were selected for full-text review. 100 studies were eligible for inclusion in our qualitative synthesis, of which 96 were included in our meta-analyses. 11 categories of co-occurring conditions were investigated, of which eight conditions were included in the meta-analyses and three were descriptively synthesised (ie, trauma and stressor-related disorders, substance-related and addictive disorders, and gender dysphoria). From our meta-analyses, we found overall pooled prevalence estimates of 28% (95% CI 25-32) for attention-deficit hyperactivity disorder; 20% (17-23) for anxiety disorders; 13% (9-17) for sleep-wake disorders; 12% (10-15) for disruptive, impulse-control, and conduct disorders; 11% (9-13) for depressive disorders; 9% (7-10) for obsessive-compulsive disorder; 5% (3-6) for bipolar disorders; and 4% (3-5) for schizophrenia spectrum disorders. Estimates in clinical sample-based studies were higher than in population-based and registry-based studies, and these estimates were mostly higher than those in the general population (post hoc). Age, gender, intellectual functioning, and country of study were associated with heterogeneity in prevalence estimates, yet remaining heterogeneity not explained was still substantial (all I2 >95%). INTERPRETATION: Co-occurring mental health conditions are more prevalent in the autism population than in the general population. Careful assessment of mental health is an essential component of care for all people on the autism spectrum and should be integrated into clinical practice. FUNDING: Academic Scholars Awards, Department of Psychiatry, University of Toronto; O'Brien Scholars Program, Slaight Family Child and Youth Mental Health Innovation Fund, and The Catherine and Maxwell Meighen Foundation via the Centre for Addiction and Mental Health Foundation.
引用
- Lai MC, Kassee C, Besney R, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019. PMID: 31447415. doi:10.1016/S2215-0366(19)30289-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。